WYAMINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Wyamine Sulfate, and what generic alternatives are available?
Wyamine Sulfate is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in WYAMINE SULFATE is mephentermine sulfate. There is one drug master file entry for this compound. Additional details are available on the mephentermine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for WYAMINE SULFATE?
- What are the global sales for WYAMINE SULFATE?
- What is Average Wholesale Price for WYAMINE SULFATE?
Summary for WYAMINE SULFATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 30 |
| Patent Applications: | 99 |
| DailyMed Link: | WYAMINE SULFATE at DailyMed |
US Patents and Regulatory Information for WYAMINE SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | WYAMINE SULFATE | mephentermine sulfate | INJECTABLE;INJECTION | 008248-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare Corp | WYAMINE SULFATE | mephentermine sulfate | INJECTABLE;INJECTION | 008248-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
